Literature DB >> 10202051

Mutations that cause the Wiskott-Aldrich syndrome impair the interaction of Wiskott-Aldrich syndrome protein (WASP) with WASP interacting protein.

D M Stewart1, L Tian, D L Nelson.   

Abstract

Wiskott-Aldrich syndrome (WAS) is an X-linked recessive disorder characterized by thrombocytopenia, eczema, immune deficiency, and a proclivity toward lymphoid malignancy. Lymphocytes of affected individuals show defects of activation, motility, and cytoskeletal structure. The disease gene encodes a 502-amino acid protein named the WAS protein (WASP). Studies have identified a number of important interactions that place WASP in a role of integrating signaling pathways with cytoskeletal function. We performed a two-hybrid screen to identify proteins interacting with WASP and cloned a proline-rich protein as a specific WASP interactor. Our clone of this protein, termed WASP interacting protein (WIP) by others, shows a difference in seven amino acid residues, compared with the previously published sequence revealing an additional profilin binding motif. Deletion mutant analysis reveals that WASP residues 101-151 are necessary for WASP-WIP interaction. Point mutant analyses in the two-hybrid system and in vitro show impairment of WASP-WIP interaction with three WASP missense mutants known to cause WAS. We conclude that impaired WASP-WIP interaction may contribute to WAS.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10202051

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  29 in total

Review 1.  The Wiskott-Aldrich syndrome.

Authors:  A J Thrasher; C Kinnon
Journal:  Clin Exp Immunol       Date:  2000-04       Impact factor: 4.330

Review 2.  Actin-based motility of intracellular microbial pathogens.

Authors:  M B Goldberg
Journal:  Microbiol Mol Biol Rev       Date:  2001-12       Impact factor: 11.056

3.  Ubiquitylation-dependent negative regulation of WASp is essential for actin cytoskeleton dynamics.

Authors:  Barak Reicher; Noah Joseph; Ahuvit David; Maor H Pauker; Orly Perl; Mira Barda-Saad
Journal:  Mol Cell Biol       Date:  2012-06-04       Impact factor: 4.272

4.  Structure-function analysis of the WIP role in T cell receptor-stimulated NFAT activation: evidence that WIP-WASP dissociation is not required and that the WIP NH2 terminus is inhibitory.

Authors:  Xiaoyun Dong; Genaro Patino-Lopez; Fabio Candotti; Stephen Shaw
Journal:  J Biol Chem       Date:  2007-08-20       Impact factor: 5.157

5.  WASP-interacting protein is important for actin filament elongation and prompt pseudopod formation in response to a dynamic chemoattractant gradient.

Authors:  Scott A Myers; Laura R Leeper; Chang Y Chung
Journal:  Mol Biol Cell       Date:  2006-08-09       Impact factor: 4.138

6.  Competition between Blown fuse and WASP for WIP binding regulates the dynamics of WASP-dependent actin polymerization in vivo.

Authors:  Peng Jin; Rui Duan; Fengbao Luo; Guofeng Zhang; Sabrina N Hong; Elizabeth H Chen
Journal:  Dev Cell       Date:  2011-05-17       Impact factor: 12.270

7.  WIP is a chaperone for Wiskott-Aldrich syndrome protein (WASP).

Authors:  Miguel A de la Fuente; Yoji Sasahara; Marco Calamito; Inés M Antón; Abdallah Elkhal; Maria D Gallego; Koduru Suresh; Katherine Siminovitch; Hans D Ochs; Kenneth C Anderson; Fred S Rosen; Raif S Geha; Narayanaswamy Ramesh
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-09       Impact factor: 11.205

8.  Disease-associated missense mutations in the EVH1 domain disrupt intrinsic WASp function causing dysregulated actin dynamics and impaired dendritic cell migration.

Authors:  Austen J J Worth; Joao Metelo; Gerben Bouma; Dale Moulding; Marco Fritzsche; Bertrand Vernay; Guillaume Charras; Giles O C Cory; Adrian J Thrasher; Siobhan O Burns
Journal:  Blood       Date:  2012-11-15       Impact factor: 22.113

9.  NPM-ALK phosphorylates WASp Y102 and contributes to oncogenesis of anaplastic large cell lymphoma.

Authors:  C A Murga-Zamalloa; V Mendoza-Reinoso; A A Sahasrabuddhe; D Rolland; S R Hwang; S R P McDonnell; A P Sciallis; R A Wilcox; V Bashur; K Elenitoba-Johnson; M S Lim
Journal:  Oncogene       Date:  2016-10-03       Impact factor: 9.867

10.  Platelet-associated IgAs and impaired GPVI responses in platelets lacking WIP.

Authors:  Hervé Falet; Michael P Marchetti; Karin M Hoffmeister; Michel J Massaad; Raif S Geha; John H Hartwig
Journal:  Blood       Date:  2009-08-19       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.